Clinical Trial Update: Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing everolimus in a cyclosporine-free regimen to a low-dose cyclosporine regimen in de novo kidney transplant patients; completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection Prevention
• Renal Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis | Conditions: Organ Transplantation, Renal Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-03-11